Korean J Med.
2019 Jun;94(3):252-262. 10.3904/kjm.2019.94.3.252.
Updated Treatment of Chronic Hepatitis B
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
- 2Division of Gastroenterology, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea. gudwns21@korea.ac.kr
- KMID: 2449422
- DOI: http://doi.org/10.3904/kjm.2019.94.3.252
Abstract
- Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma in Korea. The prevalence of HBV infection is gradually decreasing in Korea, but 3.0% of the total population still suffers from HBV- related chronic liver diseases. In this review, we summarize the updated clinical practice guideline for management of chronic hepatitis B, as revised by the Korean Association for the Study of the Liver in 2018.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Updated Treatment Guidelines for Chronic Hepatitis B
- 2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
- KASL guideline of managent of chronic hepatitis C
- A Study on Periphral T Cell Subsets in Asymptomatic HBsAg Carriers and Children with Chronic Hepatitis B and Hepatitis B vaccine Inoculated Infants
- Pre-S Defective Hepatitis B Virus in Patients with Acute and chronic Hepatitis B Virus Infection
